利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.013 秒)

    Mesylates of piperazine derivatives and process for their preparation
    3.
    发明授权
    Mesylates of piperazine derivatives and process for their preparation 失效
    哌嗪衍生物的甲磺酸酯及其制备方法

    公开(公告)号：US07030241B2

    公开(公告)日：2006-04-18

    申请号：US10468098

    申请日：2002-02-14

    申请人： Marcel P. M. van Aar ,  Stefanus J. Schouten ,  Jan Zorgdrager ,  Michiel C. Heslinga

    发明人： Marcel P. M. van Aar ,  Stefanus J. Schouten ,  Jan Zorgdrager ,  Michiel C. Heslinga

    IPC分类号： C07D403/00 ,  C07D401/00 ,  C07D405/00 ,  C07D409/00

    CPC分类号： C07D263/58

    摘要： The invention relates to the mesylates of a group of piperazine derivatives and to a process for the preparation of these mesylates in an economic way in the high yield and of high purity. According to the process of the invention the synthesis of the piperazine ring and the mesylate formation are combined in a single reaction step. The invention relates to the mesylate of compounds of the formula (I) wherein X is a bicyclic heterocyclic phenyl group and Y is methyl, ethyl (optionally substituted with fluorine), cycloalkyl (3–7C) methyl, benzyl or m-phenyl benzyl

    摘要翻译： 本发明涉及一组哌嗪衍生物的甲磺酸盐，以及以高产率和高纯度经济地制备这些甲磺酸盐的方法。 根据本发明的方法，在单个反应步骤中合并哌嗪环和甲磺酸酯形成。 本发明涉及式（I）化合物的甲磺酸酯，其中X为双环杂环苯基，Y为甲基，乙基（任选被氟取代），环烷基（3-7C）甲基，苄基或间苯基苄基

    N-OXIDES OF PYRIDYLMETHYL -PIPERAZINE AND -PIPERIDINE DERIVATIVES
    5.
    发明申请
    N-OXIDES OF PYRIDYLMETHYL -PIPERAZINE AND -PIPERIDINE DERIVATIVES 审中-公开
    吡咯并吡啶和哌啶衍生物的N-氧化物

    公开(公告)号：US20070275977A1

    公开(公告)日：2007-11-29

    申请号：US11743049

    申请日：2007-05-01

    申请人： Marcel Van Aar ,  Peter Van Amsterdam ,  Gerrit Barf ,  Johan Bakker ,  Cathaline Den Besten ,  Arnoldus Herremans ,  Jan Zorgdrager

    发明人： Marcel Van Aar ,  Peter Van Amsterdam ,  Gerrit Barf ,  Johan Bakker ,  Cathaline Den Besten ,  Arnoldus Herremans ,  Jan Zorgdrager

    IPC分类号： A61K31/496 ,  C07D405/14

    CPC分类号： C07D405/12

    摘要： N-oxides of certain pyridylmethylpiperazine and -piperidine derivatives are provided as alternatives to or as “prodrugs” of their respective parent compounds, as well as pharmaceutical compositions containing these N-oxides, methods for preparing them, and compositions comprising them. The N-oxides have the formula (a) wherein the substituents have the meanings given in the description, and wherein the oxidized nitrogen atom can be the nitrogen atom in the pyridyl ring of R5, or the nitrogen atom in the piperidine ring (when Z is carbon) or either one of the nitrogen atoms in the piperazine ring (when Z is nitrogen), or both the nitrogen atom connected to R5 via a methylene group, and the nitrogen atom in the pyridyl ring of R5, and tautomers, stereoisomers, pharmacologically acceptable salts, hydrates, and solvates thereof. In addition, the N-oxides and compositions can be used as medicaments useful in the treatment of affections or diseases of the central nervous system caused by disturbances in either the dopaminergic or serotinergic systems.

    摘要翻译： 提供某些吡啶基甲基哌嗪和哌啶衍生物的N-氧化物作为其各自母体化合物的“前体药物”的替代物或含有这些N-氧化物的药物组合物，其制备方法和包含它们的组合物。 N-氧化物具有式（a），其中取代基具有本说明书中给出的含义，其中氧化的氮原子可以是R 5的吡啶环中的氮原子，或氮 哌啶环中的一个原子（当Z为碳时）或哌嗪环中的氮原子之一（当Z为氮时），或通过亚甲基与R 5连接的氮原子， 和R 5的吡啶环中的氮原子，以及互变异构体，立体异构体，药理学上可接受的盐，水合物和溶剂化物。 此外，N-氧化物和组合物可以用作治疗由多巴胺能或血清素能系统中的紊乱引起的中枢神经系统的情感或疾病的药物。

    Vitamin D compounds and method of preparing these compounds
    6.
    发明授权
    Vitamin D compounds and method of preparing these compounds 失效
    维生素D化合物及其制备方法

    公开(公告)号：US6075015A

    公开(公告)日：2000-06-13

    申请号：US863947

    申请日：1997-05-27

    申请人： Jose P. Sestelo ,  Antonio Mourino ,  Jose L. Mascarenas ,  Sebastianus J. Halkes ,  Jan Zorgdrager ,  Gerhardus D. H. Dijkstra ,  Jan-Paul van de Velde

    发明人： Jose P. Sestelo ,  Antonio Mourino ,  Jose L. Mascarenas ,  Sebastianus J. Halkes ,  Jan Zorgdrager ,  Gerhardus D. H. Dijkstra ,  Jan-Paul van de Velde

    IPC分类号： C07C35/32 ,  C07C45/29 ,  C07C49/477 ,  C07C49/513 ,  C07C401/00 ,  A61K31/59

    CPC分类号： C07C401/00 ,  C07C35/32 ,  C07C45/292 ,  C07C49/477 ,  C07C49/513 ,  Y10S514/861 ,  Y10S514/863

    摘要： Vitamin D.sub.3 analogues of the formula (I): ##STR1## wherein R.sub.1 is hydrogen or hydroxy, R.sub.2 is (C.sub.1 -C.sub.3)alkyl, hydroxy(C.sub.1 -C.sub.3)alkyl, (C.sub.1 -C.sub.2)alkoxymethyl, (C.sub.2 -C.sub.3)alkenyl, or (C.sub.2 -C.sub.3)alkynyl, R.sub.3 is a branched or unbranched, saturated or unsaturated aliphatic 3- to 5- membered hydrocarbon or oxahydrocarbon biradical, having at least 3 atoms in the main chain and being optionally substituted with one or more substituents selected from epoxy, fluoro and hydroxy, R.sub.4 is sec. or tert. (C.sub.3 -C.sub.6)alkyl or (C.sub.3 -C.sub.6)cycloalkyl, A and B are each individually hydrogen or methyl, or A and B together from methylene. The compounds of the present invention exhibit pharmacotherapeutic activities, including in particular, the treatment of osteoporosis, renal osteodystrophy, osteomalacia, skin disorders such as psoriasis and other hyperproliferative skin diseases, eczema and dermatitis, nmyopathy, leukemia, breast and colon cancer, osteosarcomas, squamous cell carcinomas, melanoma, certain immunological disorders, and transplant rejections. Several methods of synthesis, including reaction of an ester compound of general formula (IX) with an inorganometallic compound of formula (III) followed by deprotection or, alternatively, first finalization of the C.sub.17 -side chain are also disclosed.

    摘要翻译： 式（I）的维生素D3类似物：其中R1是氢或羟基，R2是（C1-C3）烷基，羟基（C1-C3）烷基，（C1-C2）烷氧基甲基，（C2-C3）烯基或（ C 2 -C 3）炔基，R 3是支链或非支链的饱和或不饱和的脂族3-至5-元烃基或氧杂烃双基，在主链中具有至少3个原子，并且任选地被一个或多个选自环氧基， 氟和羟基，R4是秒。 或叔。 （C 3 -C 6）烷基或（C 3 -C 6）环烷基，A和B各自独立地为氢或甲基，或A和B一起为亚甲基。 本发明的化合物具有药物治疗活性，特别包括治疗骨质疏松症，肾性骨营养不良，骨软化症，皮肤疾病如牛皮癣和其它过度增生性皮肤病，湿疹和皮炎，纳米病，白血病，乳腺和结肠癌，骨肉瘤， 鳞状细胞癌，黑素瘤，某些免疫性疾病和移植排斥。 还公开了几种合成方法，包括通式（IX）的酯化合物与式（III）的无机金属化合物反应，然后进行脱保护，或者也可以首先终止C17-侧链。